Bladder Cancer - Results from #140

REVIEW UroToday

Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study. August 28, 2024

Effect of complete transurethral resection on oncologic outcomes after radiation therapy for muscle-invasive bladder cancer.: Transurethral resection in radiation therapy. August 28, 2024

The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population. August 28, 2024

Performance of a Modified 3D-T2-Weighted MRI Technique in Characterizing Bladder Cancer - Expert Commentary August 27, 2024

Multiparametric MRI-Based Deep Learning Radiomics Model for Assessing 5-Year Recurrence Risk in Non-Muscle Invasive Bladder Cancer. August 27, 2024

Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer. August 27, 2024

Patient Satisfaction with a Novel Tele-Cystoscopy Model: Expanding Access to Bladder Cancer Surveillance for Rural Patients. August 23, 2024

Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma. August 23, 2024

Salvage therapy for BCG failure with intravesical sequential gemcitabine and docetaxel in patients with recurrent NMIBC. August 22, 2024

Long-Term Results of Bladder Preservation with Twice-Daily Radiation plus 5-Flourouracil/Cisplatin or Daily Radiation plus Gemcitabine for MIBC - Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial. August 20, 2024

Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study. August 20, 2024

Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant Therapy. August 20, 2024

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update. August 20, 2024

Compressed sensing 3D T2WI radiomics model: improving diagnostic performance in muscle invasion of bladder cancer. August 20, 2024

"Factors influencing readmission patterns following radical cystectomy: An analysis of social determinants and discharge outcomes". August 19, 2024

Exposures and Bladder Cancer Risk Among Military Veterans: A Systematic Review and Meta-analysis. August 19, 2024

Economic Impact of Bladder Cancer in the USA. August 19, 2024

Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer. August 16, 2024

The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward. August 16, 2024

Predictors of Early Continence After Single-port Transvesical Robot-assisted Radical Prostatectomy. August 16, 2024

Page 8 of 517